The rational design of inhibitors of nitric oxide formation by inducible nitric oxide synthase

A novel class of compounds that block nitric oxide formation from cells overexpressing iNOS is described. A series of compounds was rationally designed as inhibitors of dimer formation of the inducible isoform of nitric oxide synthase, and subsequent nitric oxide production. The conformation of two...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2007-05, Vol.17 (9), p.2505-2508
Hauptverfasser: Whitlow, Marc, Adler, Marc, Davey, David, Huang, Qinglan, Koovakkat, Sunil, Parkinson, John F., Pham, Eric, Polokoff, Mark, Xu, Wei, Yuan, Shendong, Phillips, Gary
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2508
container_issue 9
container_start_page 2505
container_title Bioorganic & medicinal chemistry letters
container_volume 17
creator Whitlow, Marc
Adler, Marc
Davey, David
Huang, Qinglan
Koovakkat, Sunil
Parkinson, John F.
Pham, Eric
Polokoff, Mark
Xu, Wei
Yuan, Shendong
Phillips, Gary
description A novel class of compounds that block nitric oxide formation from cells overexpressing iNOS is described. A series of compounds was rationally designed as inhibitors of dimer formation of the inducible isoform of nitric oxide synthase, and subsequent nitric oxide production. The conformation of two fragments obtained from a crystal structure was utilized to design a tether connecting those same two fragments. The resulting compounds were potent dimerization inhibitors that bound to the enzyme in a similar conformation as the fragments.
doi_str_mv 10.1016/j.bmcl.2007.02.018
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70362131</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X07002053</els_id><sourcerecordid>19513334</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-91bfbd6ccdf4ee310f17b44faeaf5082aa1caf1c08c0649614b2ee65fc93fd533</originalsourceid><addsrcrecordid>eNqFkEtrFEEUhQtRzCT6B1xIb3TX7b1V1dXd4EaCGiGQTQJZWdTjllNDP2JVjzj_Pt3OQHCjq8uB7xwuH2NvECoEVB92lR1cX3GApgJeAbbP2AalkqWQUD9nG-gUlG0n78_Yec47AJQg5Ut2ho0QquZiw77fbqlIZo7TaPrCU44_xmIKRRy30cZ5SnlNY5xTdMX0O3oqwpSGP4XCHhbO7120Pf3N5MM4b02mV-xFMH2m16d7we6-fL69vCqvb75-u_x0XTqJ9Vx2aIP1yjkfJJFACNhYKYMhE2pouTHoTEAHrQMlO4XSciJVB9eJ4GshLtj74-5Dmn7uKc96iNlR35uRpn3WDQjFUeB_QexqFELIBeRH0KUp50RBP6Q4mHTQCHrVr3d61a9X_Rq4XvQvpben9b0dyD9VTr4X4N0JMNmZPiQzupifuFY1quPr0McjR4u0X5GSzi7S6MjHRG7Wfor_-uMRTk6lGQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19513334</pqid></control><display><type>article</type><title>The rational design of inhibitors of nitric oxide formation by inducible nitric oxide synthase</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Whitlow, Marc ; Adler, Marc ; Davey, David ; Huang, Qinglan ; Koovakkat, Sunil ; Parkinson, John F. ; Pham, Eric ; Polokoff, Mark ; Xu, Wei ; Yuan, Shendong ; Phillips, Gary</creator><creatorcontrib>Whitlow, Marc ; Adler, Marc ; Davey, David ; Huang, Qinglan ; Koovakkat, Sunil ; Parkinson, John F. ; Pham, Eric ; Polokoff, Mark ; Xu, Wei ; Yuan, Shendong ; Phillips, Gary</creatorcontrib><description>A novel class of compounds that block nitric oxide formation from cells overexpressing iNOS is described. A series of compounds was rationally designed as inhibitors of dimer formation of the inducible isoform of nitric oxide synthase, and subsequent nitric oxide production. The conformation of two fragments obtained from a crystal structure was utilized to design a tether connecting those same two fragments. The resulting compounds were potent dimerization inhibitors that bound to the enzyme in a similar conformation as the fragments.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2007.02.018</identifier><identifier>PMID: 17336523</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Analytical, structural and metabolic biochemistry ; Binding Sites ; Biological and medical sciences ; Cell Line, Tumor ; Chemistry, Pharmaceutical - methods ; Crystallization ; Crystallography, X-Ray ; Dimerization ; Dimerization inhibitors ; Drug Design ; Enzyme Inhibitors - chemical synthesis ; Enzyme Inhibitors - pharmacology ; Enzymes and enzyme inhibitors ; Fundamental and applied biological sciences. Psychology ; Humans ; iNOS ; Medical sciences ; Miscellaneous ; Models, Chemical ; Molecular Conformation ; Nitric Oxide Synthase Type II - antagonists &amp; inhibitors ; Oxidoreductases ; Pharmacology. Drug treatments</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2007-05, Vol.17 (9), p.2505-2508</ispartof><rights>2007 Elsevier Ltd</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-91bfbd6ccdf4ee310f17b44faeaf5082aa1caf1c08c0649614b2ee65fc93fd533</citedby><cites>FETCH-LOGICAL-c415t-91bfbd6ccdf4ee310f17b44faeaf5082aa1caf1c08c0649614b2ee65fc93fd533</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0960894X07002053$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18676928$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17336523$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Whitlow, Marc</creatorcontrib><creatorcontrib>Adler, Marc</creatorcontrib><creatorcontrib>Davey, David</creatorcontrib><creatorcontrib>Huang, Qinglan</creatorcontrib><creatorcontrib>Koovakkat, Sunil</creatorcontrib><creatorcontrib>Parkinson, John F.</creatorcontrib><creatorcontrib>Pham, Eric</creatorcontrib><creatorcontrib>Polokoff, Mark</creatorcontrib><creatorcontrib>Xu, Wei</creatorcontrib><creatorcontrib>Yuan, Shendong</creatorcontrib><creatorcontrib>Phillips, Gary</creatorcontrib><title>The rational design of inhibitors of nitric oxide formation by inducible nitric oxide synthase</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>A novel class of compounds that block nitric oxide formation from cells overexpressing iNOS is described. A series of compounds was rationally designed as inhibitors of dimer formation of the inducible isoform of nitric oxide synthase, and subsequent nitric oxide production. The conformation of two fragments obtained from a crystal structure was utilized to design a tether connecting those same two fragments. The resulting compounds were potent dimerization inhibitors that bound to the enzyme in a similar conformation as the fragments.</description><subject>Analytical, structural and metabolic biochemistry</subject><subject>Binding Sites</subject><subject>Biological and medical sciences</subject><subject>Cell Line, Tumor</subject><subject>Chemistry, Pharmaceutical - methods</subject><subject>Crystallization</subject><subject>Crystallography, X-Ray</subject><subject>Dimerization</subject><subject>Dimerization inhibitors</subject><subject>Drug Design</subject><subject>Enzyme Inhibitors - chemical synthesis</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Enzymes and enzyme inhibitors</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>iNOS</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Models, Chemical</subject><subject>Molecular Conformation</subject><subject>Nitric Oxide Synthase Type II - antagonists &amp; inhibitors</subject><subject>Oxidoreductases</subject><subject>Pharmacology. Drug treatments</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEtrFEEUhQtRzCT6B1xIb3TX7b1V1dXd4EaCGiGQTQJZWdTjllNDP2JVjzj_Pt3OQHCjq8uB7xwuH2NvECoEVB92lR1cX3GApgJeAbbP2AalkqWQUD9nG-gUlG0n78_Yec47AJQg5Ut2ho0QquZiw77fbqlIZo7TaPrCU44_xmIKRRy30cZ5SnlNY5xTdMX0O3oqwpSGP4XCHhbO7120Pf3N5MM4b02mV-xFMH2m16d7we6-fL69vCqvb75-u_x0XTqJ9Vx2aIP1yjkfJJFACNhYKYMhE2pouTHoTEAHrQMlO4XSciJVB9eJ4GshLtj74-5Dmn7uKc96iNlR35uRpn3WDQjFUeB_QexqFELIBeRH0KUp50RBP6Q4mHTQCHrVr3d61a9X_Rq4XvQvpben9b0dyD9VTr4X4N0JMNmZPiQzupifuFY1quPr0McjR4u0X5GSzi7S6MjHRG7Wfor_-uMRTk6lGQ</recordid><startdate>20070501</startdate><enddate>20070501</enddate><creator>Whitlow, Marc</creator><creator>Adler, Marc</creator><creator>Davey, David</creator><creator>Huang, Qinglan</creator><creator>Koovakkat, Sunil</creator><creator>Parkinson, John F.</creator><creator>Pham, Eric</creator><creator>Polokoff, Mark</creator><creator>Xu, Wei</creator><creator>Yuan, Shendong</creator><creator>Phillips, Gary</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20070501</creationdate><title>The rational design of inhibitors of nitric oxide formation by inducible nitric oxide synthase</title><author>Whitlow, Marc ; Adler, Marc ; Davey, David ; Huang, Qinglan ; Koovakkat, Sunil ; Parkinson, John F. ; Pham, Eric ; Polokoff, Mark ; Xu, Wei ; Yuan, Shendong ; Phillips, Gary</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-91bfbd6ccdf4ee310f17b44faeaf5082aa1caf1c08c0649614b2ee65fc93fd533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Analytical, structural and metabolic biochemistry</topic><topic>Binding Sites</topic><topic>Biological and medical sciences</topic><topic>Cell Line, Tumor</topic><topic>Chemistry, Pharmaceutical - methods</topic><topic>Crystallization</topic><topic>Crystallography, X-Ray</topic><topic>Dimerization</topic><topic>Dimerization inhibitors</topic><topic>Drug Design</topic><topic>Enzyme Inhibitors - chemical synthesis</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Enzymes and enzyme inhibitors</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>iNOS</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Models, Chemical</topic><topic>Molecular Conformation</topic><topic>Nitric Oxide Synthase Type II - antagonists &amp; inhibitors</topic><topic>Oxidoreductases</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Whitlow, Marc</creatorcontrib><creatorcontrib>Adler, Marc</creatorcontrib><creatorcontrib>Davey, David</creatorcontrib><creatorcontrib>Huang, Qinglan</creatorcontrib><creatorcontrib>Koovakkat, Sunil</creatorcontrib><creatorcontrib>Parkinson, John F.</creatorcontrib><creatorcontrib>Pham, Eric</creatorcontrib><creatorcontrib>Polokoff, Mark</creatorcontrib><creatorcontrib>Xu, Wei</creatorcontrib><creatorcontrib>Yuan, Shendong</creatorcontrib><creatorcontrib>Phillips, Gary</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Whitlow, Marc</au><au>Adler, Marc</au><au>Davey, David</au><au>Huang, Qinglan</au><au>Koovakkat, Sunil</au><au>Parkinson, John F.</au><au>Pham, Eric</au><au>Polokoff, Mark</au><au>Xu, Wei</au><au>Yuan, Shendong</au><au>Phillips, Gary</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The rational design of inhibitors of nitric oxide formation by inducible nitric oxide synthase</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2007-05-01</date><risdate>2007</risdate><volume>17</volume><issue>9</issue><spage>2505</spage><epage>2508</epage><pages>2505-2508</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>A novel class of compounds that block nitric oxide formation from cells overexpressing iNOS is described. A series of compounds was rationally designed as inhibitors of dimer formation of the inducible isoform of nitric oxide synthase, and subsequent nitric oxide production. The conformation of two fragments obtained from a crystal structure was utilized to design a tether connecting those same two fragments. The resulting compounds were potent dimerization inhibitors that bound to the enzyme in a similar conformation as the fragments.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>17336523</pmid><doi>10.1016/j.bmcl.2007.02.018</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2007-05, Vol.17 (9), p.2505-2508
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_70362131
source MEDLINE; Elsevier ScienceDirect Journals
subjects Analytical, structural and metabolic biochemistry
Binding Sites
Biological and medical sciences
Cell Line, Tumor
Chemistry, Pharmaceutical - methods
Crystallization
Crystallography, X-Ray
Dimerization
Dimerization inhibitors
Drug Design
Enzyme Inhibitors - chemical synthesis
Enzyme Inhibitors - pharmacology
Enzymes and enzyme inhibitors
Fundamental and applied biological sciences. Psychology
Humans
iNOS
Medical sciences
Miscellaneous
Models, Chemical
Molecular Conformation
Nitric Oxide Synthase Type II - antagonists & inhibitors
Oxidoreductases
Pharmacology. Drug treatments
title The rational design of inhibitors of nitric oxide formation by inducible nitric oxide synthase
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T22%3A38%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20rational%20design%20of%20inhibitors%20of%20nitric%20oxide%20formation%20by%20inducible%20nitric%20oxide%20synthase&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Whitlow,%20Marc&rft.date=2007-05-01&rft.volume=17&rft.issue=9&rft.spage=2505&rft.epage=2508&rft.pages=2505-2508&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2007.02.018&rft_dat=%3Cproquest_cross%3E19513334%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19513334&rft_id=info:pmid/17336523&rft_els_id=S0960894X07002053&rfr_iscdi=true